Technologies

Clinics & Hospitals

RetinAI Discovery® Platform - Unlocking the Power of Data

Today, many healthcare providers are forced to navigate a sea of unstructured and disorganized patient data. From a clinical and research standpoint, this lack of structure and accessibility limits the extent to which organizations can develop their daily routine work.

RetinAI has developed a data management platform to efficiently process data at scale across imaging types and devices. At the simple press of a keystroke, healthcare professionals can navigate imaging data, compute imaging biomarkers and track changes over time for some of the most common forms of eye diseases through a web browser.

RetinAI Discovery® uses unique medical image and data management to organize and structure the information generated routinely in a clinic or during a clinical study. AI models provide insights on biomarkers and automatic segmentation and quantification layers and fluid in retinal pathologies.

Researchers and clinicians can track changes in volumes and obtain measurements of these imaging biomarkers over multiple timepoints, saving valuable effort in assessing disease progression in a single working environment.

Interested in learning more?

*Disclaimer

RetinAI Discovery® platform, RetinAI OCT Atlas® and Macula Biomarkers, as well as LuxIA® (Diabetic Retinopathy Screening model) are CE-marked medical devices in accordance with the Medical Devices Regulation (EU) 2017/745 (CE2797). RetinAI Discovery® platform is also a medical device cleared for clinical use by the FDA. The AI modules for biomarkers, fluid, and layer segmentation and quantification in retinal pathologies are designated as Research Use Only (RUO) in the USA. Please be advised that these tools are not intended to replace professional medical advice, diagnosis, or treatment. We do not warrant or guarantee the clinical accuracy, completeness, or usefulness of any content provided by RUO products. For more information, please read our Privacy Notice (https://www.retinai.com/privacy-policy) and Data Processing Agreement (https://www.retinai.com/data-processing-agreement).

RetinAI Discovery® and RetinAI® are trademarks of Ikerian AG.